7/7/2010

Trial May Advance Personalized Medicine

If you are newly diagnosed, find out whether you are eligible to participate in I-SPY2, a trial measuring the effectiveness of adding new medicines to standard chemotherapy given before surgery. Read more ...

Ongoing

Trial for Young Women Studies Effectiveness of Goserelin to Prevent Early Menopause

A randomized phase III clinical trial for young women with stage I-IIIA hormone receptor-negative breast cancer compares the effectiveness of ovarian suppression using goserelin combined with chemotherapy versus chemotherapy alone in preventing early menopause. Read more ...